HOMEZ expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.600600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.366000E-01
Normal-vs-Stage2
9.920600E-01
Normal-vs-Stage3
1.845810E-01
Normal-vs-Stage4
6.400600E-01
Stage1-vs-Stage2
2.866400E-01
Stage1-vs-Stage3
9.344300E-02
Stage1-vs-Stage4
8.869600E-01
Stage2-vs-Stage3
1.137810E-01
Stage2-vs-Stage4
5.962400E-01
Stage3-vs-Stage4
2.414800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.619800E-01
Normal-vs-AfricanAmerican
9.645400E-01
Normal-vs-Asian
4.517400E-01
Caucasian-vs-AfricanAmerican
9.942600E-01
Caucasian-vs-Asian
4.953500E-02
AfricanAmerican-vs-Asian
3.236600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.395000E-01
Normal-vs-Female
9.973200E-01
Male-vs-Female
7.697400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.637200E-01
Normal-vs-Age(41-60Yrs)
5.851800E-01
Normal-vs-Age(61-80Yrs)
7.545400E-01
Normal-vs-Age(81-100Yrs)
5.141000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.687000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.885000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.891800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.836300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.320200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.674100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.477400E-01
Normal-vs-Daily Drinker
4.785000E-01
Normal-vs-Weekly Drinker
9.646200E-01
Normal-vs-Occasional Drinker
3.546200E-01
Normal-vs-Social Drinker
6.648800E-01
Non Drinker-vs-Daily Drinker
4.162800E-01
Non Drinker-vs-Weekly Drinker
6.925600E-01
Non Drinker-vs-Occasional Drinker
1.144370E-02
Non Drinker-vs-Social Drinker
1.961180E-01
Daily Drinker-vs-Weekly Drinker
3.570400E-01
Daily Drinker-vs-Occasional Drinker
2.978900E-03
Daily Drinker-vs-Social Drinker
4.603700E-02
Weekly Drinker-vs-Occasional Drinker
1.503350E-01
Weekly Drinker-vs-Social Drinker
6.050600E-01
Occasional Drinker-vs-Social Drinker
1.886560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.603700E-02
Normal-vs-Grade 2
2.358200E-02
Normal-vs-Grade 3
8.582400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.309400E-01
Grade 1-vs-Grade 3
3.082800E-01
Grade 1-vs-Grade 4
6.603700E-02
Grade 2-vs-Grade 3
1.931370E-01
Grade 2-vs-Grade 4
2.358200E-02
Grade 3-vs-Grade 4
8.582400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.210600E-01
Normal-vs-NonDiabetic
9.316200E-01
Diabetic-vs-NonDiabetic
3.065000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.245400E-01
Normal-vs-NoPancreatitis
9.905800E-01
Pancreatitis-vs-NoPancreatitis
3.251800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.207200E-01
Normal-vs-N1
9.673600E-01
N0-vs-N1
5.942200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.133800E-01
Normal-vs-TP53-NonMutant
8.023600E-01
TP53-Mutant-vs-TP53-NonMutant
4.030000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
